Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain

BACKGROUND: Philadelphia chromosome-negative (Ph−) relapsed or refractory (R/R) B-cell precursor acute lymphoblastic leukaemia (ALL) is rare, and information on its impact on healthcare systems is scarce. OBJECTIVE: To quantify the time and reimbursement associated with hospitalisations of patients...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharmacoecon Open
Asıl Yazarlar: Boluda, Blanca, Rodríguez-Veiga, Rebeca, Martínez-Cuadrón, David, Lorenzo, Ignacio, Sanz, Jaime, Regadera, Ana, Sempere, Amparo, Senent, Leonor, Cervera, Jose Vicente, Solves, Pilar, Reitan, John, Gea, Salvador, Sanz, Miguel Angel, Montesinos, Pau
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2018
Konular:
Original Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6533337/
https://ncbi.nlm.nih.gov/pubmed/30324566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41669-018-0098-8
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller